Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study - Wikidata - awgldk - TriplyDB

Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study

Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study

http://www.wikidata.org/entity/Q33688308

about

Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study

http://www.wikidata.org/entity/Q33688308

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Comparative effectiveness of a ...... abetes: A 15-year cohort study

@ast

Comparative effectiveness of a ...... abetes: A 15-year cohort study

@en

type

label

Comparative effectiveness of a ...... abetes: A 15-year cohort study

@ast

Comparative effectiveness of a ...... abetes: A 15-year cohort study

@en

prefLabel

Comparative effectiveness of a ...... abetes: A 15-year cohort study

@ast

Comparative effectiveness of a ...... abetes: A 15-year cohort study

@en

P1433

Q33688308-BFBECA74-FD7B-4286-89FC-C3C75EE10B77

P1476

Q33688308-150BBE06-516F-4D75-AC07-F6334D514B88

P2093

Q33688308-1D907DC4-A18D-4D8F-81FC-027DD72545CE

Q33688308-503658AC-6AB6-4AED-8979-6BC20D6E4AC3

Q33688308-515846A7-CBD7-43A8-B4B8-60E0B7716A56

Q33688308-75B779C3-95CD-4E8C-A58E-EAB8F146DF26

Q33688308-E05F36A3-36B2-44AF-A733-1FCAD1D45BEC

Q33688308-F9881220-7605-4A69-AEC6-3743D2BBFCCA

P2860

Q33688308-000CBD55-A53A-4562-9984-CF7E088946AE

Q33688308-0B2189C2-C15B-4803-B3FF-C6F89107967F

Q33688308-0E2C253B-1185-4A65-BAC6-3173EDD9D11D

Q33688308-0EE62D13-ECCE-43F9-A363-2CCB5C07BCCB

Q33688308-16913B78-06E9-457D-853F-283DEC8330B2

Q33688308-24F55350-AA8C-407D-AC5D-5E278B7C85F8

Q33688308-4343BE65-C272-4024-B13F-FC5E68B408A3

Q33688308-4C0078BD-86EB-44F5-8935-3639668ACEAA

Q33688308-68C0718C-5402-4D6F-B164-DAC7FF294840

Q33688308-6AA8A225-261D-44BE-A535-0D9E9A543F17

P304

Q33688308-7938E6E1-8E81-4CF7-85E1-0E7108AEC91D

P31

Q33688308-F8A1E29C-B99B-4AE8-86F9-C7D90AD67FDA

P356

Q33688308-E5E01876-01E8-42A6-AAFA-CC365748BC9C

P407

Q33688308-0F98D651-7124-4AF8-93F9-64B776EA9983

P433

Q33688308-9A9E73F7-2EB2-4840-8EF9-27EF9ECF0A52

P478

Q33688308-212D41C6-B242-4DAD-B2C1-A60A73F0E784

P50

Q33688308-130A6256-C09E-48A4-AA2D-8684544E9181

Q33688308-1F225626-FEF2-4F7F-9AF5-7DFCB5EE2E9C

Q33688308-2A8FFAFE-7E22-44F1-A83B-B40A89C80418

Q33688308-428745FB-ADAF-4215-B442-34B5FE16EF2B

Q33688308-605A5003-0160-4F67-820A-75F4B10F3CAF

Q33688308-8FA0022E-BA64-43A6-B64D-AD041EE2466F

Q33688308-A7AFE67C-FAE1-4C56-9F8E-219236C8B68E

Q33688308-E43DF3E8-72D1-4B78-BD7B-8F7B40B47668

Q33688308-EC24BFFB-C6E0-4091-8000-A4D27D97FBD5

P577

Q33688308-2FA812DF-3B1F-468F-BDE9-CD056942C7A2

P698

Q33688308-03015B4D-3D94-40AA-8724-D9C6EDC6D57C

P932

Q33688308-F949DEF6-7CB0-4B3E-98CB-D75AA1E8347A

P356

JOURNAL.PONE.0177654

P1433

P1476

Comparative effectiveness of a ...... abetes: A 15-year cohort study

@en

P2093

Chee-Jen Chang

http://www.w3.org/2001/XMLSchema#string

Chiao-Ling Peng

http://www.w3.org/2001/XMLSchema#string

Hon-Yen Wu

http://www.w3.org/2001/XMLSchema#string

Pei-Chun Chen

http://www.w3.org/2001/XMLSchema#string

Tzong-Shinn Chu

http://www.w3.org/2001/XMLSchema#string

Yu-Sen Peng

http://www.w3.org/2001/XMLSchema#string

P2860

Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method.

Renal and retinal effects of enalapril and losartan in type 1 diabetes

Chronic kidney disease: global dimension and perspectives.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis.

Estimation of expected life-years saved from successful prevention of end-stage renal disease in elderly patients with diabetes: a nationwide study from Taiwan.

P304

e0177654

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0177654

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Chih-Kang Chiang

Kuo-Liong Chien

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28505194

http://www.w3.org/2001/XMLSchema#string

P932

5432180

http://www.w3.org/2001/XMLSchema#string